Allergic Rhinitis and Its Impact on Asthma (ARIA 2008 $). The Polish perspective;ARIA 2008 $ z polskiej perspektywy

Alergia Astma Immunologia

Volumn 13, Issue 1, 2008, Pages 10-15

  Kowalski, Marek L ^a   Nizankowska Mogilnicka, Ewa ^b   Szczeklik, Andrzej ^b   Brȩborowicz, Anna ^c   Bodzenta Łukaszczyk, Anna ^d   Chazan, Ryszada ^e   Górski, Paweł ^c   Jassem, Ewa ^c   Jutel, Marek ^f   Kruszewski, Jerzy ^g   Kulus, Marek ^c   Kurzawa, Ryszard ^h   Panaszek, Bernard ^f   Pawliczak, Rafał ^c   Pierzchała, Władysław ⁱ   Rogala, Barbara ^j   Samoliński, Bolesław ^e   Khaltaev, Nikolai ^k   Bousquet, Jean ^l  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c AM ^*  (Poland)

^d AM   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g MILITARY INSTITUTE OF MEDICINE   (Poland)

^h Klinika Alergologii I Pneumonologii Instytutu Gru licy I Chorób P uc   (Poland)

ⁱ MEDICAL UNIVERSITY OF SILESIA   (Poland)

^j Katedra i Klinika Chorob Wewnetrznych   (Poland)

^k WORLD HEALTH ORGANIZATION   (Switzerland)

^l HÔPITAL ARNAUD DE VILLENEUVE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ALLERGIC RHINITIS; ASTHMA; HUMAN; IMMUNOTHERAPY; LOWER RESPIRATORY TRACT; MEDICAL INFORMATION; MORBIDITY; PATIENT CARE; POLAND; PUBLICATION; RESPIRATORY TRACT ALLERGY; REVIEW; UPPER RESPIRATORY TRACT;

EID: 46749083813     PISSN: 14273101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007; 62 Suppl 85: 17-25.
2. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy. 2007; 62 Suppl 85: 9-16.
3. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007Aug; 120(2): 381-7.
4. Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy. 2007 Sep; 62(9): 1057-63.
5. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007 Mar; 62(3): 216-23.
6. Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. ISBN 978 92 4 156346 8. 2007: 148 pages.
7. Asher Mt, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK i wsp., et al Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006Aug 26; 368(9537): 733-43.
8. Ait-Khaled N, Odhiambo J, Pearce N, Adjoh KS, Maesano IA, Benhabyles B i wsp, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy. 2007 Mar; 62(3): 247-58.
9. Pekkarinen PT, von Hertzen L, Laatikainen T, Makela MJ, Jousilahti P, Kosunen TU i wsp, et al. A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia. Allergy. 2007 Mar; 62(3): 281-7.
10. Majkowska-Wojciechowska B, Pelka J, Korzon L, Kozlowska A, Kaczala M, Jarzebska M i wsp., et al. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy. 2007 Sep; 62(9): 1044-50.
11. Viinanen A, Munhbayarlah S, Zevgee T, Narantsetseg L, Naidansuren T, Koskenvuo M i wsp., et al. The protective effect of rural living against atopy in Mongolia. Allergy. 2007 Mar; 62(3): 272-80.
12. van Ree R, Yazdanbakhsh M. Allergic disorders in African countries: linking immunology to accurate phenotype. Allergy. 2007 Mar; 62(3): 237-46.
13. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001; 108(5 Suppl): S147-334.
14. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BmjMJ. 1999; 318(7183): 593-6.
15. Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy. 2005 Sep; 60(9): 1112-5.
16. Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, Lockey RF, Niggemann B i wsp, et al. ARIA update: I - Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006 May; 117(5): 1054-62.
17. Bonini S, Bonini M, Bousquet J, Brusasco V, Canonica GW, Carlsen KH i wsp., et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy. 2006 Jun; 61(6): 681-92.
18. Bousquet J, van Cauwenberge P, Ait Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J i wsp, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy. 2006 Sep; 61(9): 1086-96.
19. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. JAllergy Clin Immunol. 2007 Apr; 119(4): 881-91.
20. Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J i wsp, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007; 62 Suppl 84: 1-41.
21. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004 Nov; 24(5): 758-64.
22. Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy. 2003 Jul; 58(7): 672-5.
23. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006 Jun; 61(6): 693-8.
24. Todo-Bom A, Loureiro C, Almeida MM, Nunes C, Delgado L, Castel-Branco G i wsp, et al. Epidemiology of rhinitis in Portugal: evaluation of the intermittent and the persistent types. Allergy 2007 Sep; 62(9): 1038-43.
25. Van Hoecke H, Vastesaeger N, Dewulf L, De Bacquer D, van Cauwenberge P. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol. 2006 Sep; 118(3): 758-9.
26. Valero A, Ferrer M, Sastre J, Navarro AM, Monclus L, Marti-Guadano E i wsp, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol, 2007 Aug; 120(2): 359-65.
27. Bonini M, Lapucci G, Petrelli G, Todaro A, Pamich T, Rasi G i wsp, et al. Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. Allergy. 2007 Oct; 62(10): 1166-70.
28. Burgess JA, Walters EH, Byrnes GB, Matheson MC, Jenkins MA, Wharton CL i wsp, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol. 2007 Oct; 120(4): 863-9.
29. Chatkin MN, Menezes AM, Victora CG, Barros FC. High prevalence of asthma in preschool children in Southern Brazil: a population-based study. Pediatric pPulmonology. 2003 Apr; 35(4): 296-301.
30. Giovannini M, Agostoni C, Riva E, Salvini F, Ruscitto A, Zuccotti GV i wsp, et al. A Randomized Prospective Double Blind Controlled Trial on Effects of Long-Term Consumption of Fermented Milk Containing Lactobacillus casei in Pre-School Children With Allergic Asthma and/or Rhinitis. Pediatr Res 2007 Jun 25; 62: 215-20
31. Choi SH, Yoo Y, Yu J, Rhee CS, Min YG, Koh YY. Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy. 2007 Sep; 62(9): 1051-6.
32. Bateman ED, JithooA. Asthma and allergy - a global perspective Allergy. 2007 Mar; 62(3): 213-5.
33. English RG, Fairall LR, Bateman ED. Keeping allergy on the agenda: integrated guidelines for respiratory disease in developing countries. Allergy. 2007 Mar; 62(3): 224-9.
34. Bousquet J, Khaltaev N, Cruz A, Denburg J, Fokkens W, Weel CV i wsp, et al. ARIA Update. Allergy. 2008; 63(suppl): 8-160
35. Schunemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L i wsp, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med. 2007 May; 4(5): e119.
36. Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG i wsp, et al. Methodology for development of the Allergic Rhinitis and its Impact onAsthma guideline 2008 update. Allergy. 2008 Jan; 63(1): 38-46.
37. Kaiser HB, Naclerio RM, Given J, Toler TN, EllsworthA, Philpot EE. Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Apr 4; 119: 1430-37.
38. Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C i wsp., et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007 Sep; 62(9): 1078-84.
39. Devillier P, Bousquet J. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy? Clin Exp Allergy. 2007 Mar; 37(3): 400-14.
40. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J i wsp, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004 Oct; 114(4): 838-44.
41. Canonica GW, Bousquet J, Van Hammee G, Bachert C, Durham SR, Klimek L, i wspet al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med. 2006; 100: 1706-15 May 22.
42. Virchow JC, Bachert C. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir Med. 2006; 100: 1952-59 Apr 12..
43. Philip G, NayakAS, Berger WE, Leynadier F, Vrijens F, Dass SB i wsp, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin. 2004 Oct; 20(10): 1549-58.
44. Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy. 2007 Jan; 62(1): 73-80.
45. Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy. 2007Aug; 62(8): 954-7.
46. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006 Apr; 117(4): 802-9.
47. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W i wsp, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006 Aug; 118(2): 434-40.
48. Didier A, Malling HJ, Worm M, Horak F, Jager S, Montagut A i wsp, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Dec; 120(6): 1338-45.
49. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ i wsp, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy. 2007 Mar, 62(3): 317-24.
50. Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2008; 121: 105-1097 Oct 26.
51. Molgaard E, Thomsen SF, Lund T, Pedersen L, Nolte H, Backer V. Differences between allergic and nonallelic rhinitis in a large sample of adolescents and adults. Allergy. 2007; 62: 1033-7.
52. Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol. 2006 Nov; 118(5): 985-98.
53. Linneberg A, Jorgensen T, Nielsen NH, Madsen F, Frolund L, Dirksen A. The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy. 2000 Aug; 55(8): 767-72.
54. Terreehorst I, Oosting AJ, Tempels-Pavlica Z, de Monchy JG, Bruijnzeel-Koomen CA, Hak E i wsp, et al. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy. 2002 Aug; 32(8): 1160-5.
55. Georgy V, Fahim HI, El Gaafary M, Walters S. Prevalence and socioeconomic associations of asthma and allergic rhinitis in Cairo, Egypt. Eur Respir J. 2006; 28: 756-62 May 31.
56. Kuyucu S, Saraclar Y, Tuncer A, Geyik PO, Adalioglu G, Akpinarli A i wsp, et al. Epidemiologic characteristics of rhinitis in Turkish children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol. 2006 Jun; 17(4): 269-77.
57. Antonicelli L, Micucci C, Voltolini S, Feliziani V, Senna GE, Di Blasi P i wsp, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin ExpAllergy. 2007 Jun; 37(6): 954-60.
58. Antonicelli L, Micucci C, Voltolini S, Senna GE, Di Blasi P, Visona G i wsp, et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy. 2007 Sep; 62(9): 1064-70.
59. Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest. 2005 Nov; 128(5): 3140-7.
60. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy. 2007 Mar; 62(3): 310-6.
61. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007 Aug; 62(8): 943-8.
62. Civelek E, Soyer OU, Gemicioglu B, Sekerel BE. Turkish physicians' perception of allergic rhinitis and its impact on asthma. Allergy. 2006 Dec; 61(12): 1454-8.
63. Demoly P, Concas V, Urbinelli R, Allaert F. Evaluation de l'influence des recommandations OMS-ARIA sur la prise en charge de la rhinite allergique en pratique de ville en France. Engquȩte ERNANI. Rev fFr Allergol Immunol Clin. 2006; 46: 626-32.
64. Malolepszy J, Liebhart J. Prevalence of allergy In Poland. Alergia Astma Immunologia 2000; 5 (supl.2): 163-169.
65. Lis G, BrȩborowiczA, Cichocka-Jarosz E, Sobkowiak P, Gazurek D, SwiatlyA, Alkiewicz J, Pietrzyk JJ. The prevalence of allergic rhinitis and conjunctivitis in school children from Krakow and Poznan - ISAAC study (International Study of Asthma and Allergies in Childhood). Otolaryngol Pol. 2004; 58(6): 1103-9.
66. Bjorkstein B, Clayton T, Ellwood P, Stewart A, Strachan D and the ISAAC Phase III study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the international Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 2008; 19: 110-124.
67. Sozanska B, MacNeill SJ, Kajderowicz-Kowalik M, Danielewicz H Wheatley M, Newman Taylor AJ, Bozanski A, Cullinan P. Atopy and asthma in rural Poland: a paradigm for the emergence of childhood respiratory allergies in Europe. Allergy. 2007; 62: 394-400.
68. Samoliński B, Raciborski F, Tomaszewska A, Jakubik N, Marszałkowska J, Krzych-Fałta E, Samel-Kowalik P, Walkiewicz A, Życinska K. Czȩstość wystȩpowania objawów nieżytów nosa i astmy w Polsce - badania ECAP. Doniesienia wstȩpne. Familily Medicine. 2007; 9: 596-601.
69. Tomaszewska A, Raciborski F, Samel-Kowalik P, Samoliński B. Czȩstotliwość wystȩpowania alergicznego nieżytu nosa w wybranych regionach Polski. Analiza miasto-wieś. Otolaryngologia Polska. 2007; LXI: 550-554.
70. Bousquet J, van Cauwenberge PB, Khaltaev N i wsp. Alergiczny nieżyt nosa i jego wpływ na astmȩ. Raport ARIA. Med Prakt. wyd. specj. 7/2002.
71. Bousquet i wsp. Postȩpowanie z alergicznym nieżycie nosa - zakres kompetencji farmaceuty. ARIA dla farmaceutów. Alergia Astma Immunologia 2004; 9: (4), 163-168.